Fear of Cancer Recurrence in Sarcoma Survivors: Results from the SURVSARC Study

Fear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in sarcoma survivors; (2) the factors associated with a higher level of FCR; the relationship between (3) FCR and global health status and (4) F...

Full description

Saved in:
Bibliographic Details
Published inCancers Vol. 14; no. 24; p. 6099
Main Authors Pellegrini, Ilaria, Drabbe, Cas, Grünhagen, Dirk J, Van de Sande, Michiel A J, de Haan, Jacco J, Keymeulen, Kristien B M I, Bonenkamp, Johannes J, Van der Graaf, Winette T A, Husson, Olga
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 11.12.2022
MDPI
Subjects
Breast cancer
Cancer
Cancer survivors
Care and treatment
Comorbidity
Comparative analysis
Data collection
Fear
Health aspects
Likert scale
Patient outcomes
Patients
Psychological aspects
Public health
Quality of life
Questionnaires
Relapse
Sarcoma
Statistical analysis
Survival
Tumors
Netherlands
follow-up
health-related quality of life
fear of cancer recurrence
sarcoma
survivors
Online AccessGet full text

Cover

Abstract Fear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in sarcoma survivors; (2) the factors associated with a higher level of FCR; the relationship between (3) FCR and global health status and (4) FCR and use of follow-up care. A cross-sectional study was conducted among sarcoma survivors 2 to 10 years after diagnosis. Patients completed the Cancer Worry Scale (CWS), the global health status subscale of the EORTC QLQ-C30 and a custom-made questionnaire on follow-up care. In total, 1047 patients were included (response rate 55%). The prevalence of high FCR was 45%. Factors associated with high FCR were female sex with 1.6 higher odds (95% CI 1.22-2.25; = 0.001); having ≥1 comorbidities and receiving any treatment other than surgery alone with 1.5 (95% CI 1.07-2.05; = 0.017) and 1.4 (95% CI 1.06-1.98; = 0.020) higher odds, respectively. Patients on active follow-up had 1.7 higher odds (95% CI 1.20-2.61; = 0.004) and patients with higher levels of FCR scored lower on the global health status scale (72 vs. 83 ≤ 0.001). Severe FCR is common in sarcoma survivors and high levels are related to a decreased global health status. FCR deserves more attention in sarcoma survivorship, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.
AbstractList Fear of cancer recurrence is often reported as an unmet concern by cancer patients, and, to our knowledge, it has not been assessed yet in sarcoma survivors. We conducted a population-based cross sectional questionnaire study to assess the prevalence and characteristics of fear of cancer recurrence amongst sarcoma survivors. We demonstrated that severe fear of cancer recurrence is common in sarcoma survivors and that high levels are associated with decreased global health status. Fear of cancer recurrence deserves more attention in optimal sarcoma survivorship care. To guarantee adequate patient care, the collaboration between health care professionals should be encouraged, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.
Fear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in sarcoma survivors; (2) the factors associated with a higher level of FCR; the relationship between (3) FCR and global health status and (4) FCR and use of follow-up care. METHODSA cross-sectional study was conducted among sarcoma survivors 2 to 10 years after diagnosis. Patients completed the Cancer Worry Scale (CWS), the global health status subscale of the EORTC QLQ-C30 and a custom-made questionnaire on follow-up care. RESULTSIn total, 1047 patients were included (response rate 55%). The prevalence of high FCR was 45%. Factors associated with high FCR were female sex with 1.6 higher odds (95% CI 1.22-2.25; p = 0.001); having ≥1 comorbidities and receiving any treatment other than surgery alone with 1.5 (95% CI 1.07-2.05; p = 0.017) and 1.4 (95% CI 1.06-1.98; p = 0.020) higher odds, respectively. Patients on active follow-up had 1.7 higher odds (95% CI 1.20-2.61; p = 0.004) and patients with higher levels of FCR scored lower on the global health status scale (72 vs. 83 p ≤ 0.001). CONCLUSIONSSevere FCR is common in sarcoma survivors and high levels are related to a decreased global health status. FCR deserves more attention in sarcoma survivorship, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.
Fear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in sarcoma survivors; (2) the factors associated with a higher level of FCR; the relationship between (3) FCR and global health status and (4) FCR and use of follow-up care. Methods: A cross-sectional study was conducted among sarcoma survivors 2 to 10 years after diagnosis. Patients completed the Cancer Worry Scale (CWS), the global health status subscale of the EORTC QLQ-C30 and a custom-made questionnaire on follow-up care. Results: In total, 1047 patients were included (response rate 55%). The prevalence of high FCR was 45%. Factors associated with high FCR were female sex with 1.6 higher odds (95% CI 1.22–2.25; p = 0.001); having ≥1 comorbidities and receiving any treatment other than surgery alone with 1.5 (95% CI 1.07–2.05; p = 0.017) and 1.4 (95% CI 1.06–1.98; p = 0.020) higher odds, respectively. Patients on active follow-up had 1.7 higher odds (95% CI 1.20–2.61; p = 0.004) and patients with higher levels of FCR scored lower on the global health status scale (72 vs. 83 p ≤ 0.001). Conclusions: Severe FCR is common in sarcoma survivors and high levels are related to a decreased global health status. FCR deserves more attention in sarcoma survivorship, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.
Simple SummaryFear of cancer recurrence is often reported as an unmet concern by cancer patients, and, to our knowledge, it has not been assessed yet in sarcoma survivors. We conducted a population-based cross sectional questionnaire study to assess the prevalence and characteristics of fear of cancer recurrence amongst sarcoma survivors. We demonstrated that severe fear of cancer recurrence is common in sarcoma survivors and that high levels are associated with decreased global health status. Fear of cancer recurrence deserves more attention in optimal sarcoma survivorship care. To guarantee adequate patient care, the collaboration between health care professionals should be encouraged, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.AbstractFear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in sarcoma survivors; (2) the factors associated with a higher level of FCR; the relationship between (3) FCR and global health status and (4) FCR and use of follow-up care. Methods: A cross-sectional study was conducted among sarcoma survivors 2 to 10 years after diagnosis. Patients completed the Cancer Worry Scale (CWS), the global health status subscale of the EORTC QLQ-C30 and a custom-made questionnaire on follow-up care. Results: In total, 1047 patients were included (response rate 55%). The prevalence of high FCR was 45%. Factors associated with high FCR were female sex with 1.6 higher odds (95% CI 1.22–2.25; p = 0.001); having ≥1 comorbidities and receiving any treatment other than surgery alone with 1.5 (95% CI 1.07–2.05; p = 0.017) and 1.4 (95% CI 1.06–1.98; p = 0.020) higher odds, respectively. Patients on active follow-up had 1.7 higher odds (95% CI 1.20–2.61; p = 0.004) and patients with higher levels of FCR scored lower on the global health status scale (72 vs. 83 p ≤ 0.001). Conclusions: Severe FCR is common in sarcoma survivors and high levels are related to a decreased global health status. FCR deserves more attention in sarcoma survivorship, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.
Fear of cancer recurrence is often reported as an unmet concern by cancer patients, and, to our knowledge, it has not been assessed yet in sarcoma survivors. We conducted a population-based cross sectional questionnaire study to assess the prevalence and characteristics of fear of cancer recurrence amongst sarcoma survivors. We demonstrated that severe fear of cancer recurrence is common in sarcoma survivors and that high levels are associated with decreased global health status. Fear of cancer recurrence deserves more attention in optimal sarcoma survivorship care. To guarantee adequate patient care, the collaboration between health care professionals should be encouraged, and structured support programs should be developed to deliver interventions in a correct and time adequate environment. Fear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in sarcoma survivors; (2) the factors associated with a higher level of FCR; the relationship between (3) FCR and global health status and (4) FCR and use of follow-up care. Methods: A cross-sectional study was conducted among sarcoma survivors 2 to 10 years after diagnosis. Patients completed the Cancer Worry Scale (CWS), the global health status subscale of the EORTC QLQ-C30 and a custom-made questionnaire on follow-up care. Results: In total, 1047 patients were included (response rate 55%). The prevalence of high FCR was 45%. Factors associated with high FCR were female sex with 1.6 higher odds (95% CI 1.22–2.25; p = 0.001); having ≥1 comorbidities and receiving any treatment other than surgery alone with 1.5 (95% CI 1.07–2.05; p = 0.017) and 1.4 (95% CI 1.06–1.98; p = 0.020) higher odds, respectively. Patients on active follow-up had 1.7 higher odds (95% CI 1.20–2.61; p = 0.004) and patients with higher levels of FCR scored lower on the global health status scale (72 vs. 83 p ≤ 0.001). Conclusions: Severe FCR is common in sarcoma survivors and high levels are related to a decreased global health status. FCR deserves more attention in sarcoma survivorship, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.
Fear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in sarcoma survivors; (2) the factors associated with a higher level of FCR; the relationship between (3) FCR and global health status and (4) FCR and use of follow-up care. A cross-sectional study was conducted among sarcoma survivors 2 to 10 years after diagnosis. Patients completed the Cancer Worry Scale (CWS), the global health status subscale of the EORTC QLQ-C30 and a custom-made questionnaire on follow-up care. In total, 1047 patients were included (response rate 55%). The prevalence of high FCR was 45%. Factors associated with high FCR were female sex with 1.6 higher odds (95% CI 1.22-2.25; = 0.001); having ≥1 comorbidities and receiving any treatment other than surgery alone with 1.5 (95% CI 1.07-2.05; = 0.017) and 1.4 (95% CI 1.06-1.98; = 0.020) higher odds, respectively. Patients on active follow-up had 1.7 higher odds (95% CI 1.20-2.61; = 0.004) and patients with higher levels of FCR scored lower on the global health status scale (72 vs. 83 ≤ 0.001). Severe FCR is common in sarcoma survivors and high levels are related to a decreased global health status. FCR deserves more attention in sarcoma survivorship, and structured support programs should be developed to deliver interventions in a correct and time adequate environment.
Audience Academic
Author Husson, Olga
Drabbe, Cas
Keymeulen, Kristien B M I
Bonenkamp, Johannes J
Van der Graaf, Winette T A
Pellegrini, Ilaria
de Haan, Jacco J
Grünhagen, Dirk J
Van de Sande, Michiel A J
AuthorAffiliation 2 Department of Medical Oncology, IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
7 Department of Surgical Oncology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
3 Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands
8 Department of Surgical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
1 Department of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
4 Department of Surgical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands
5 Department of Orthopaedic Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
9 Division of Clinical Studies, Institute of Cancer Research, London SM2 5NG, UK
6 Department of Medical Oncology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
AuthorAffiliation_xml – name: 3 Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands
– name: 5 Department of Orthopaedic Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
– name: 7 Department of Surgical Oncology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
– name: 8 Department of Surgical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
– name: 1 Department of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands
– name: 2 Department of Medical Oncology, IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
– name: 4 Department of Surgical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands
– name: 6 Department of Medical Oncology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
– name: 9 Division of Clinical Studies, Institute of Cancer Research, London SM2 5NG, UK
Author_xml – sequence: 1
  givenname: Ilaria
  surname: Pellegrini
  fullname: Pellegrini, Ilaria
  organization: Department of Medical Oncology, IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
– sequence: 2
  givenname: Cas
  surname: Drabbe
  fullname: Drabbe, Cas
  organization: Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands
– sequence: 3
  givenname: Dirk J
  orcidid: 0000-0001-8293-6002
  surname: Grünhagen
  fullname: Grünhagen, Dirk J
  organization: Department of Surgical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands
– sequence: 4
  givenname: Michiel A J
  orcidid: 0000-0002-9156-7656
  surname: Van de Sande
  fullname: Van de Sande, Michiel A J
  organization: Department of Orthopaedic Surgery, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands
– sequence: 5
  givenname: Jacco J
  orcidid: 0000-0002-1629-4715
  surname: de Haan
  fullname: de Haan, Jacco J
  organization: Department of Medical Oncology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands
– sequence: 6
  givenname: Kristien B M I
  surname: Keymeulen
  fullname: Keymeulen, Kristien B M I
  organization: Department of Surgical Oncology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands
– sequence: 7
  givenname: Johannes J
  surname: Bonenkamp
  fullname: Bonenkamp, Johannes J
  organization: Department of Surgical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands
– sequence: 8
  givenname: Winette T A
  orcidid: 0000-0001-7549-3338
  surname: Van der Graaf
  fullname: Van der Graaf, Winette T A
  organization: Department of Medical Oncology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands
– sequence: 9
  givenname: Olga
  orcidid: 0000-0002-1387-8686
  surname: Husson
  fullname: Husson, Olga
  organization: Division of Clinical Studies, Institute of Cancer Research, London SM2 5NG, UK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36551585$$D View this record in MEDLINE/PubMed
BookMark eNptks9LHDEUx0OxVLt67q0EevGymt-Z6aGwLLUtCMKO7TW8ySQamZnYZGbB_77Zaq2KL4c8ks_7Ju_He7Q3xtEh9IGSE85rcmphtC5lKphQpK7foANGNFsqVYu9J_4-Osr5hhTjnGql36F9rqSkspIH6OLMQcLR4_VfMbxxdk7JFR-HETeQbBwAN3Pahm1M-XMB8txPGfsUBzxdO9z83PxqVps1bqa5uztEbz302R097At0efb1cv19eX7x7cd6db60oqqmZQetd0wwsOUrrRdcdSBBc1VTsKArC0QLxhRRShPacaiE5po4bWXbas8X6Mu97O3cDq6zbpwS9OY2hQHSnYkQzPObMVybq7g1tdZK0qoIHD8IpPh7dnkyQ8jW9T2MLs7ZMC0rSpikdUE_vUBv4pzGkt2OUsVqJv9TV9A7E0Yfy7t2J2pWWkimuSj1X6CTV6iyOjcEW9rrQzl_FnB6H2BTzDk5_5gjJWY3BebFFJSIj09L88j_6zn_A_qerjk
CitedBy_id crossref_primary_10_1097_OR9_0000000000000113
crossref_primary_10_1016_j_ijchp_2023_100434
crossref_primary_10_1200_CCI_24_00054
Cites_doi 10.1093/annonc/mdz124
10.1136/esmoopen-2020-000914
10.1016/j.esmoop.2021.100258
10.1002/pon.1570
10.1007/s11764-020-00911-w
10.1016/j.ejca.2011.04.034
10.1002/cncr.33181
10.1093/jnci/85.5.365
10.15252/emmm.201911131
10.3109/0284186X.2014.1003960
10.1002/pon.3114
10.1016/j.esmoop.2021.100047
10.1007/s11764-013-0272-z
10.1016/S1470-2045(17)30445-X
10.3389/fpsyg.2021.596682
10.1016/j.canep.2015.03.002
10.1038/sj.bjc.6690197
10.4065/mcp.2009.0248
10.4103/ijmr.IJMR_915_14
10.1097/NCC.0b013e3182813a17
10.1007/s11136-019-02214-9
10.1007/s11606-009-1017-6
10.1016/j.ijsu.2006.01.005
10.1186/s12955-018-0920-0
10.1093/annonc/mdx484
10.3109/0284186X.2016.1150607
10.1002/pon.4757
10.1207/S15324796ABM2501_03
10.1097/01.sla.0000250438.04393.a8
10.1136/bmj.313.7058.665
10.1038/sj.bjc.6605638
10.1002/cncr.32518
10.1200/JCO.2006.06.7207
10.1007/s00520-008-0444-y
10.1007/s00520-019-04979-8
ContentType Journal Article
Copyright COPYRIGHT 2022 MDPI AG
2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: COPYRIGHT 2022 MDPI AG
– notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID NPM
AAYXX
CITATION
3V.
7T5
7TO
7XB
8FE
8FH
8FK
8G5
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
GNUQQ
GUQSH
H94
HCIFZ
LK8
M2O
M7P
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.3390/cancers14246099
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Immunology Abstracts
Oncogenes and Growth Factors Abstracts
ProQuest Central (purchase pre-March 2016)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni Edition)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central
ProQuest Central Student
Research Library Prep
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Biological Science Collection
Research Library
Biological Science Database
Research Library (Corporate)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Biological Science Database
ProQuest SciTech Collection
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
Publicly Available Content Database

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 2072-6694
ExternalDocumentID A745273403
10_3390_cancers14246099
36551585
Genre Journal Article
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GrantInformation_xml – fundername: The PROFILES registry was funded by an Investment Grant Medium (#480-08-009) of the Neth-erlands Organization for Scientific Research (The Hague, the Netherlands). The present research was supported by an Investment Grant Large 2016/04981/ZONMW-91101002)
  grantid: (198.007)
– fundername: Netherlands Organization for Scientific Research
  grantid: #480-08-009; 2016/04981/ZONMW-91101002
– fundername: Social Psychology Fellowship from the Dutch Cancer Society; Netherlands Organization for Scientific Research VIDI grant
  grantid: 198.007
GroupedDBID ---
3V.
53G
5VS
8FE
8FH
8G5
AADQD
AAFWJ
ABDBF
ABUWG
ADBBV
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
CCPQU
DIK
DWQXO
E3Z
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HCIFZ
HYE
IAO
IHR
ITC
KQ8
LK8
M2O
M48
M7P
MODMG
M~E
NPM
OK1
P6G
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RPM
TUS
AAYXX
CITATION
7T5
7TO
7XB
8FK
H94
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
AFPKN
ID FETCH-LOGICAL-c488t-dabfe242ac365bf436da5a73691aca78ca074226066701d3a847370e7c5bb7f3
IEDL.DBID RPM
ISSN 2072-6694
IngestDate Tue Sep 17 21:32:18 EDT 2024
Fri Oct 25 01:29:15 EDT 2024
Thu Oct 10 18:07:22 EDT 2024
Tue Nov 19 21:42:37 EST 2024
Tue Nov 12 23:53:27 EST 2024
Fri Nov 22 02:28:11 EST 2024
Wed Oct 16 00:41:45 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 24
Keywords follow-up
health-related quality of life
fear of cancer recurrence
sarcoma
survivors
Language English
License Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c488t-dabfe242ac365bf436da5a73691aca78ca074226066701d3a847370e7c5bb7f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ORCID 0000-0001-8293-6002
0000-0001-7549-3338
0000-0002-9156-7656
0000-0002-1387-8686
0000-0002-1629-4715
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776518/
PMID 36551585
PQID 2756666925
PQPubID 2032421
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9776518
proquest_miscellaneous_2758102519
proquest_journals_2756666925
gale_infotracmisc_A745273403
gale_infotracacademiconefile_A745273403
crossref_primary_10_3390_cancers14246099
pubmed_primary_36551585
PublicationCentury 2000
PublicationDate 20221211
PublicationDateYYYYMMDD 2022-12-11
PublicationDate_xml – month: 12
  year: 2022
  text: 20221211
  day: 11
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Cancers
PublicationTitleAlternate Cancers (Basel)
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Blay (ref_5) 2017; 28
Thewes (ref_17) 2012; 20
Vos (ref_36) 2020; 15
Aaronson (ref_31) 1993; 85
Gatta (ref_2) 2017; 18
(ref_21) 2020; 30
Soomers (ref_28) 2020; 126
Grunfeld (ref_33) 1999; 79
Haraldstad (ref_12) 2019; 28
Qlg (ref_9) 2018; 16
Gutierrez (ref_7) 2007; 245
Simard (ref_15) 2008; 17
Thewes (ref_27) 2017; 26
Johns (ref_41) 2020; 126
Younger (ref_11) 2021; 6
Drabbe (ref_39) 2021; 6
ref_37
Blay (ref_6) 2019; 30
Haggstrom (ref_34) 2009; 24
Custers (ref_24) 2015; 54
Trautmann (ref_4) 2015; 39
Lebel (ref_16) 2012; 21
Hollander (ref_10) 2020; 5
Ayanian (ref_8) 2006; 24
Custers (ref_25) 2016; 24
Kaba (ref_42) 2007; 5
Liu (ref_19) 2019; 27
ref_22
Horevoorts (ref_29) 2011; 47
Douma (ref_30) 2009; 19
Alonso (ref_3) 2020; 12
Shaw (ref_20) 2021; 12
Longtin (ref_43) 2010; 85
Custers (ref_23) 2014; 37
ref_1
Hall (ref_40) 2018; 27
Schouten (ref_26) 2016; 55
Vickberg (ref_14) 2003; 25
Simard (ref_18) 2013; 7
Murchie (ref_35) 2010; 102
Pillai (ref_13) 2017; 145
Crist (ref_38) 2012; 22
Grunfeld (ref_32) 1996; 313
References_xml – volume: 30
  start-page: 1143
  year: 2019
  ident: ref_6
  article-title: Surgery in reference centers improves survival of sarcoma patients: A nationwide study
  publication-title: Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.
  doi: 10.1093/annonc/mdz124
  contributor:
    fullname: Blay
– volume: 5
  start-page: e000914
  year: 2020
  ident: ref_10
  article-title: Unravelling the heterogeneity of soft tissue and bone sarcoma patients’ health-related quality of life: A systematic literature review with focus on tumour location
  publication-title: ESMO Open
  doi: 10.1136/esmoopen-2020-000914
  contributor:
    fullname: Hollander
– volume: 20
  start-page: 2651
  year: 2012
  ident: ref_17
  article-title: Fear of cancer recurrence in young women with a history of early-stage breast cancer: A cross-sectional study of prevalence and association with health behaviours
  publication-title: Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer
  contributor:
    fullname: Thewes
– volume: 6
  start-page: 100258
  year: 2021
  ident: ref_11
  article-title: Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: Baseline results from the HOLISTIC study
  publication-title: ESMO Open
  doi: 10.1016/j.esmoop.2021.100258
  contributor:
    fullname: Younger
– volume: 19
  start-page: 289
  year: 2009
  ident: ref_30
  article-title: Psychological distress and use of psychosocial support in familial adenomatous polyposis
  publication-title: Psycho-Oncology
  doi: 10.1002/pon.1570
  contributor:
    fullname: Douma
– volume: 15
  start-page: 66
  year: 2020
  ident: ref_36
  article-title: Survivorship care for cancer patients in primary versus secondary care: A systematic review
  publication-title: J. Cancer Surviv.
  doi: 10.1007/s11764-020-00911-w
  contributor:
    fullname: Vos
– volume: 21
  start-page: 901
  year: 2012
  ident: ref_16
  article-title: Does fear of cancer recurrence predict cancer survivors’ health care use?
  publication-title: Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer
  contributor:
    fullname: Lebel
– volume: 26
  start-page: 1479
  year: 2017
  ident: ref_27
  article-title: Prevalence and correlates of high fear of cancer recurrence in late adolescents and young adults consulting a specialist adolescent and young adult (AYA) cancer service
  publication-title: Support. Care Cancer
  contributor:
    fullname: Thewes
– volume: 47
  start-page: 2188
  year: 2011
  ident: ref_29
  article-title: The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2011.04.034
  contributor:
    fullname: Horevoorts
– volume: 126
  start-page: 5283
  year: 2020
  ident: ref_28
  article-title: Patient and diagnostic intervals of survivors of sarcoma: Results from the SURVSARC study
  publication-title: Cancer
  doi: 10.1002/cncr.33181
  contributor:
    fullname: Soomers
– volume: 85
  start-page: 365
  year: 1993
  ident: ref_31
  article-title: The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
  publication-title: J. Natl. Cancer Inst.
  doi: 10.1093/jnci/85.5.365
  contributor:
    fullname: Aaronson
– volume: 12
  start-page: e11131
  year: 2020
  ident: ref_3
  article-title: Sarcoma treatment in the era of molecular medicine
  publication-title: EMBO Mol. Med.
  doi: 10.15252/emmm.201911131
  contributor:
    fullname: Alonso
– volume: 54
  start-page: 1202
  year: 2015
  ident: ref_24
  article-title: Fear of progression in patients with gastrointestinal stromal tumors (GIST): Is extended lifetime related to the Sword of Damocles?
  publication-title: Acta Oncol.
  doi: 10.3109/0284186X.2014.1003960
  contributor:
    fullname: Custers
– ident: ref_37
– volume: 24
  start-page: 555
  year: 2016
  ident: ref_25
  article-title: Fear of cancer recurrence in colorectal cancer survivors
  publication-title: Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer
  contributor:
    fullname: Custers
– volume: 22
  start-page: 978
  year: 2012
  ident: ref_38
  article-title: Factors reported to influence fear of recurrence in cancer patients: A systematic review
  publication-title: Psycho-Oncology
  doi: 10.1002/pon.3114
  contributor:
    fullname: Crist
– ident: ref_1
– volume: 6
  start-page: 100047
  year: 2021
  ident: ref_39
  article-title: The age-related impact of surviving sarcoma on health-related quality of life: Data from the SURVSARC study
  publication-title: ESMO Open
  doi: 10.1016/j.esmoop.2021.100047
  contributor:
    fullname: Drabbe
– volume: 7
  start-page: 300
  year: 2013
  ident: ref_18
  article-title: Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies
  publication-title: J. Cancer Surviv. Res. Pract.
  doi: 10.1007/s11764-013-0272-z
  contributor:
    fullname: Simard
– volume: 18
  start-page: 1022
  year: 2017
  ident: ref_2
  article-title: Burden and centralised treatment in Europe of rare tumours: Results of RARECAREnet-a population-based study
  publication-title: Lancet Oncol.
  doi: 10.1016/S1470-2045(17)30445-X
  contributor:
    fullname: Gatta
– volume: 30
  start-page: 134
  year: 2020
  ident: ref_21
  article-title: Integrating fear of cancer recurrence screening into routine care: Opportunities and challenges
  publication-title: Psycho-Oncology
– volume: 12
  start-page: 596682
  year: 2021
  ident: ref_20
  article-title: Setting an International Research Agenda for Fear of Cancer Recurrence: An Online Delphi Consensus Study
  publication-title: Front. Psychol.
  doi: 10.3389/fpsyg.2021.596682
  contributor:
    fullname: Shaw
– volume: 39
  start-page: 440
  year: 2015
  ident: ref_4
  article-title: Burden of soft-tissue and bone sarcoma in routine care: Estimation of incidence, prevalence and survival for health services research
  publication-title: Cancer Epidemiol.
  doi: 10.1016/j.canep.2015.03.002
  contributor:
    fullname: Trautmann
– volume: 79
  start-page: 1227
  year: 1999
  ident: ref_33
  article-title: Follow-up of breast cancer in primary care vs specialist care: Results of an economic evaluation
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6690197
  contributor:
    fullname: Grunfeld
– volume: 85
  start-page: 53
  year: 2010
  ident: ref_43
  article-title: Patient Participation: Current Knowledge and Applicability to Patient Safety
  publication-title: Mayo Clin. Proc.
  doi: 10.4065/mcp.2009.0248
  contributor:
    fullname: Longtin
– volume: 145
  start-page: 17
  year: 2017
  ident: ref_13
  article-title: Rare cancers: Challenges & issues
  publication-title: Indian J. Med Res.
  doi: 10.4103/ijmr.IJMR_915_14
  contributor:
    fullname: Pillai
– volume: 37
  start-page: E44
  year: 2014
  ident: ref_23
  article-title: The Cancer Worry Scale: Detecting fear of recurrence in breast cancer survivors
  publication-title: Cancer Nurs.
  doi: 10.1097/NCC.0b013e3182813a17
  contributor:
    fullname: Custers
– volume: 28
  start-page: 2641
  year: 2019
  ident: ref_12
  article-title: A systematic review of quality of life research in medicine and health sciences
  publication-title: Qual. Life Res.
  doi: 10.1007/s11136-019-02214-9
  contributor:
    fullname: Haraldstad
– volume: 24
  start-page: S472
  year: 2009
  ident: ref_34
  article-title: Follow-up Care Delivery Among Colorectal Cancer Survivors Most Often Seen by Primary and Subspecialty Care Physicians
  publication-title: J. Gen. Intern. Med.
  doi: 10.1007/s11606-009-1017-6
  contributor:
    fullname: Haggstrom
– volume: 5
  start-page: 57
  year: 2007
  ident: ref_42
  article-title: The evolution of the doctor-patient relationship
  publication-title: Int. J. Surg.
  doi: 10.1016/j.ijsu.2006.01.005
  contributor:
    fullname: Kaba
– volume: 16
  start-page: 114
  year: 2018
  ident: ref_9
  article-title: Understanding the quality of life (QOL) issues in survivors of cancer: Towards the development of an EORTC QOL cancer survivorship questionnaire
  publication-title: Health Qual. Life Outcomes
  doi: 10.1186/s12955-018-0920-0
  contributor:
    fullname: Qlg
– volume: 28
  start-page: 2852
  year: 2017
  ident: ref_5
  article-title: Improved survival using specialized multidisciplinary board in sarcoma patients
  publication-title: Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.
  doi: 10.1093/annonc/mdx484
  contributor:
    fullname: Blay
– volume: 55
  start-page: 821
  year: 2016
  ident: ref_26
  article-title: Fear of cancer recurrence in prostate cancer survivors
  publication-title: Acta Oncol.
  doi: 10.3109/0284186X.2016.1150607
  contributor:
    fullname: Schouten
– volume: 27
  start-page: 2546
  year: 2018
  ident: ref_40
  article-title: Mind-body interventions for fear of cancer recurrence: A systematic review and meta-analysis
  publication-title: Psycho-Oncology
  doi: 10.1002/pon.4757
  contributor:
    fullname: Hall
– volume: 25
  start-page: 16
  year: 2003
  ident: ref_14
  article-title: The concerns about recurrence scale (CARS): A systematic measure of women’s fears about the possibility of breast cancer recurrence
  publication-title: Ann. Behav. Med.
  doi: 10.1207/S15324796ABM2501_03
  contributor:
    fullname: Vickberg
– volume: 245
  start-page: 952
  year: 2007
  ident: ref_7
  article-title: Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients
  publication-title: Ann. Surg.
  doi: 10.1097/01.sla.0000250438.04393.a8
  contributor:
    fullname: Gutierrez
– ident: ref_22
– volume: 313
  start-page: 665
  year: 1996
  ident: ref_32
  article-title: Routine follow up of breast cancer in primary care: Randomised trial
  publication-title: BMJ
  doi: 10.1136/bmj.313.7058.665
  contributor:
    fullname: Grunfeld
– volume: 102
  start-page: 1447
  year: 2010
  ident: ref_35
  article-title: Patient satisfaction with GP-led melanoma follow-up: A randomised controlled trial
  publication-title: Br. J. Cancer
  doi: 10.1038/sj.bjc.6605638
  contributor:
    fullname: Murchie
– volume: 126
  start-page: 211
  year: 2020
  ident: ref_41
  article-title: Acceptance and commitment therapy for breast cancer survivors with fear of cancer recurrence: A 3-arm pilot randomized controlled trial
  publication-title: Cancer
  doi: 10.1002/cncr.32518
  contributor:
    fullname: Johns
– volume: 24
  start-page: 5149
  year: 2006
  ident: ref_8
  article-title: Enhancing research on cancer survivors
  publication-title: J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.
  doi: 10.1200/JCO.2006.06.7207
  contributor:
    fullname: Ayanian
– volume: 17
  start-page: 241
  year: 2008
  ident: ref_15
  article-title: Fear of Cancer Recurrence Inventory: Development and initial validation of a multidimensional measure of fear of cancer recurrence
  publication-title: Support. Care Cancer
  doi: 10.1007/s00520-008-0444-y
  contributor:
    fullname: Simard
– volume: 27
  start-page: 4055
  year: 2019
  ident: ref_19
  article-title: Systematic review of interventions by non-mental health specialists for managing fear of cancer recurrence in adult cancer survivors
  publication-title: Support. Care Cancer
  doi: 10.1007/s00520-019-04979-8
  contributor:
    fullname: Liu
SSID ssj0000331767
Score 2.3646092
Snippet Fear of cancer recurrence (FCR) is often reported as an unmet concern by cancer patients. The aim of our study was to investigate (1) the prevalence of FCR in...
Fear of cancer recurrence is often reported as an unmet concern by cancer patients, and, to our knowledge, it has not been assessed yet in sarcoma survivors....
Simple SummaryFear of cancer recurrence is often reported as an unmet concern by cancer patients, and, to our knowledge, it has not been assessed yet in...
SourceID pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 6099
SubjectTerms Breast cancer
Cancer
Cancer survivors
Care and treatment
Comorbidity
Comparative analysis
Data collection
Fear
Health aspects
Likert scale
Patient outcomes
Patients
Psychological aspects
Public health
Quality of life
Questionnaires
Relapse
Sarcoma
Statistical analysis
Survival
Tumors
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1da9RAcNEriFCk1o-etrKCoC-hu9nsbuJLuR4tRWiVu1b6FvYjiwVN6uVO8N87k-xdmz4Y8rYTMszMztfOzBLywUmpQ2GLxOYhhwDFqCTnqkiUrViQ1vOgsFH4_EKdXWVfruV1TLi1saxyrRM7Re0bhznyQxxTDk-RyqPb3wneGoWnq_EKjcdkKwVXRo7I1vHJxbfZJsvCBNhHpfuZPgLi-0OHxFy02OClWDfx9c4cPVTK96zSsGLyngk63SHPou9IJz2zn5NHVb1LnpzH0_Fdst3n4GjfWvSCfAX_bkGbQKcdNnSGufWuu4_e1HQOIt78MnS-Am3xp1m0nwGgXf1cthR7Tih4hnR-Nfs-n8ymFMsN_74kl6cnl9OzJF6gkDjYl8vEGxsqsMHGCSVtyITyRhotVMGNMzp3BiPjFGMYzbgXBkyV0KzSTlqrg3hFRnVTV3uEhuBSHiQT3pnMZsYy76XmWahynxbMjcmnNRnL235MRgnhBVK8fEDxMfmIZC5xAwEtnYl9APAjHEVVTnSGQ-EyJsZkfwAJgu-Gy2tGlXHjteWdmIzJ-80yfonFZHXVrDqYnGNsBbi87vm6QRoIBR5eDl_rAcc3ADiOe7hS3_zoxnKDJ60kz9_8H6235GmKHRQcXr5PRsvFqjoAv2Zp30Xh_QebsvlN
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdbB2UvpVu_0mZDg0L74tayLMkujBHCShlkhaQpfTOSbNFAa7d2Upr_vneOk9WlTzN-0x0Sdyfd_ey7EyGHVgjlYhN7JnIRABQtvYjJ2JMm850wKXMSC4UHf-XFOPxzI27-XQfUCLB6F9rhfVLj8u7k-XH-Czb8T0ScANlPLcqnrLBmS0LA85F8CkIeYH7foIn162OZg6uUatHe5z2-lmd6ez6_clDt5MlX3uh8k2w0YSTtLfT-hXzI8q9kfdD8KN8ilxDalbRwtF_PTof4Wb0u7KOTnI7Auot7TUczOCieirI6A4JqdjetKJabUAgK6Wg8vB71hn2KmYbzbXJ1_vuqf-E1dyd4Frbk1Eu1cRm4X225FMaFXKZaaMVlzLTVKrIaQXGA8EX5LOUavBRXfqasMEY5vkPW8iLP9gh1zgbMCZ-nVocm1MZPU6FY6LIoDWLfdsjxUmzJw6JDRgLIAiWcvJFwhxyhWBPUJsjO6qYEACbCLlRJT4XYDy70eYd0W5Rg87Y9vFRMsjSZBBvZwxMHokN-rIaRE_PI8qyY1TQRQ1gFa9ld6HG1aBAUBHcRcKuWhlcE2Im7PZJPbuuO3BBES8Gi_f_mPCCfA6yrYPCyLlmblrPsG0Q7U_O9tuIXjbACdw
  priority: 102
  providerName: Scholars Portal
Title Fear of Cancer Recurrence in Sarcoma Survivors: Results from the SURVSARC Study
URI https://www.ncbi.nlm.nih.gov/pubmed/36551585
https://www.proquest.com/docview/2756666925
https://search.proquest.com/docview/2758102519
https://pubmed.ncbi.nlm.nih.gov/PMC9776518
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swED6aDsZexn4vWxc0GGwvbizLkuy9ZaFdGaQrSTvyZiTZooHGLnEy2H-_O8fJ4j7OGL_ohMTppLvPvvsM8MlJqX1q08AmPkGAYlSQcJUGyhahlzbnXlGh8ORSXdzEP-ZyfgRyVwvTJO07uzgt75an5eK2ya28X7rhLk9seDUZY8yiJE-GPehhbHgA0ZvjV6BLVHpL4yMQ0g8d6W9VU02XChuS138e6OE5fOCIukmSB17n_Bk8bcNFNtpO6zkcFeULeDxpP4i_hJ8Ywq1Y5dm4GZ1N6fV5U8DHFiWboRVXS8NmGzwQfler-isK1Ju7dc2orIRh8MdmN9Nfs9F0zCij8M8ruD4_ux5fBO0_EgKHW28d5Mb6At2scUJJ62OhciONFirlxhmdOEPgNyKYokOeC4PeSOiw0E5aq714DcdlVRZvgXnvIu5lKHJnYhsbG-a51Dz2RZJHaej68GWntux-y4SRIYIgDWcPNNyHz6TWjPYI6s6ZNtUfByK2qWykY-J9i0PRh5OOJNq26zbvFiZr91adEWE9Xmkk-_Bx30w9KV-sLKpNI5Nwgk84lzfbddxPGhWFQVyCvXVnhfcCxLjdbUFDbJi3W8N7998938OTiOonON78BI7Xq03xAaOatR3Ao29nl1fTAfS-zzk-J3EyaCz7L_Pq_Z0
link.rule.ids 230,315,729,782,786,887,2223,21395,24325,27931,27932,33751,33752,43812,53798,53800,74309
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BJwESQjC-CgOMhAQv0eI4thNeUKk2FVgLaju0t8h2YjEJktG0SPz33CVpt-yBKG92lNPd-b7s-xngjZNS-9SmgU18ggmKUUHCVRooW4Re2px7RY3C05manMafz-RZV3Cru2OVW5vYGOq8clQjPySYcnzSSH64-B3QrVG0u9pdoXET9giqKhrA3sej2bf5rsoSCvSPSreYPgLz-0NHzFzV1OClwgbx9dIdXTfKV7xS_8TkFRd0fB_udbEjG7XCfgA3inIfbk273fF9uNvW4FjbWvQQvmJ8t2KVZ-OGGjan2nrT3cfOS7ZAFa9-GbbYoLX4U63q9zih3vxc14x6ThhGhmxxOv--GM3HjI4b_n0Ey-Oj5XgSdBcoBA7X5TrIjfUF-mDjhJLWx0LlRhotVMqNMzpxhjLjiHIYHfJcGHRVQoeFdtJa7cVjGJRVWTwF5r2LuJehyJ2JbWxsmOdS89gXSR6loRvCuy0bs4sWJiPD9II4nl3j-BDeEpszWkDIS2e6PgD8EUFRZSMdEyhcHIohHPRmouK7_vBWUFm38OrsUk2G8Ho3TF_SYbKyqDbNnIRTboW0PGnluiMaGYURXoJf657EdxMIjrs_Up7_aGC5MZJWkifP_k_WK7g9WU5PspNPsy_P4U5E3RQcX34Ag_VqU7zAGGdtX3aK_A9l9Pw1
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJNmpAQggGjMMBISPAS1Y5jO-EFlbJqfKxM7Yb2FtlOrE0ayWhaJP49d4nbLXsgypsvinXfd747E_LWSal9ZrPIpj6FAMWoKOUqi5QtmZe24F5ho_DRVB2eJl_P5Fmof2pCWeVaJ7aKuqgd5siHOKYcniyWQx_KIo4_Tz5e_Y7wBik8aQ3Xadwl22AVGXD49qeD6fFsk3FhAmyl0t18HwGx_tAhYhcNNnsp1k5_vTZNtxX0DQvVr568YY4mD8mD4EfSUUf4R-ROWe2SnaNwUr5L7nf5ONq1GT0mP8DXW9Da03G7GzrDPHvb6UcvKjoHdq9_GTpfgeb4Uy-aDwDQrC6XDcX-EwpeIp2fzn7OR7MxxdLDv0_IyeTgZHwYhcsUIgcyuowKY30J9tg4oaT1iVCFkUYLlXHjjE6dwSg5xnhGM14IA2ZLaFZqJ63VXjwlW1Vdlc8I9d7F3EsmCmcSmxjLikJqnvgyLeKMuQF5v0ZjftWNzMgh1ECM57cwPiDvEM05ChPg0pnQEwA_wrFU-UgnOCAuYWJA9nuQIASuv7wmVB6EsMmvWWZA3myW8UssLKvKetXCpBzjLNjLXkfXzaYBUeDtpfC17lF8A4Cjufsr1cV5O6IbvGolefr8_9t6TXaAh_PvX6bfXpB7MTZWcHj5PtlaLlblS3B3lvZV4ON_Jy4Aeg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fear+of+Cancer+Recurrence+in+Sarcoma+Survivors%3A+Results+from+the+SURVSARC+Study&rft.jtitle=Cancers&rft.au=Pellegrini%2C+Ilaria&rft.au=Drabbe%2C+Cas&rft.au=Gr%C3%BCnhagen%2C+Dirk+J.&rft.au=Van+de+Sande%2C+Michiel+A.+J.&rft.date=2022-12-11&rft.pub=MDPI&rft.eissn=2072-6694&rft.volume=14&rft.issue=24&rft_id=info:doi/10.3390%2Fcancers14246099&rft.externalDBID=PMC9776518
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6694&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6694&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6694&client=summon